0.3517
Biodesix Inc stock is traded at $0.3517, with a volume of 837.25K.
It is down -7.08% in the last 24 hours and up +24.63% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.3785
Open:
$0.3875
24h Volume:
837.25K
Relative Volume:
0.10
Market Cap:
$51.55M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-0.5411
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-15.80%
1M Performance:
+24.63%
6M Performance:
-65.85%
1Y Performance:
-78.62%
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BDSX
Biodesix Inc
|
0.3517 | 55.47M | 49.09M | -52.15M | -45.93M | -0.65 |
![]()
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
Jul-26-24 | Initiated | Craig Hallum | Buy |
May-13-24 | Initiated | TD Cowen | Buy |
May-03-24 | Initiated | Lake Street | Buy |
Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-23-20 | Initiated | BTIG Research | Buy |
Nov-23-20 | Initiated | Canaccord Genuity | Buy |
Nov-23-20 | Initiated | Morgan Stanley | Overweight |
Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
How does Biodesix Inc. generate profit in a changing economyAdvanced Screener Entry Points For Consistent Profits - jammulinksnews.com
What catalysts could drive Biodesix Inc. stock higher in 2025Market Forecast Updates That Work - jammulinksnews.com
Biodesix (BDSX) to Release Earnings on Thursday - MarketBeat
What makes Biodesix Inc. stock price move sharplyBeginner Investor Opportunities To Watch Now - jammulinksnews.com
Why Biodesix Inc. stock attracts strong analyst attentionStock Market Entry Timing Signals Revealed - beatles.ru
Published on: 2025-07-29 23:34:00 - metal.it
Using economic indicators to assess Biodesix Inc. potentialFree Expert Verified Stock Trade Ideas - Newser
Biodesix Inc. stock trend forecastBuy Zone Strategy with Pattern Recognition - Newser
The Market Lifts Biodesix, Inc. (NASDAQ:BDSX) Shares 67% But It Can Do More - simplywall.st
Developing predictive dashboards with Biodesix Inc. dataConsistent Profit Signals with AI Models - Newser
Heatmap Data Shows High Activity in Biodesix Inc. SectorTrend Analysis for Safer Trades Gains Popularity - metal.it
RSI Crosses Above 30 for Biodesix Inc. — Reversal in SightPattern Detection for Entry Confirmation Enabled - metal.it
How Biodesix Inc. stock performs during market volatilityExit Ready Momentum Stock Watchlist Expanded - metal.it
Should I hold or sell Biodesix Inc. stock in 2025Free Predictions - jammulinksnews.com
Price momentum metrics for Biodesix Inc. explainedFree Swing Trade With Risk Management - Newser
What are analysts’ price targets for Biodesix Inc. in the next 12 monthsSuperior risk-adjusted returns - jammulinksnews.com
Does Biodesix Inc. stock perform well during market downturnsGet expert advice on portfolio optimization - jammulinksnews.com
How many analysts rate Biodesix Inc. as a “Buy”Capitalize on emerging market opportunities - jammulinksnews.com
What is the risk reward ratio of investing in Biodesix Inc. stockFree Stock Index Interpretation - jammulinksnews.com
Is it the right time to buy Biodesix Inc. stockBuild wealth faster with consistent growth stocks - jammulinksnews.com
How does Biodesix Inc. compare to its industry peersUnlock your portfolio’s hidden potential - jammulinksnews.com
Biodesix Inc. Company’s Quarterly Earnings Growth: What the Numbers SayMassive Profit Potential - Newser
Sectors Driving Future Growth for Biodesix Inc. StockHigh Potential Safe Trades - Newser
Biodesix Inc. Stock Analysis and ForecastExceptional stock performance - PrintWeekIndia
What analysts say about Biodesix Inc. stockFree Bull & Bear Market Updates - PrintWeekIndia
Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers - MSN
Is Biodesix Inc. a good long term investmentBreakthrough wealth creation - Autocar Professional
Is Biodesix Inc. stock a growth or value playHigh-octane financial growth - jammulinksnews.com
Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire
AIGH Capital Management LLC Sells 1,907,221 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
How Biodesix Inc. stock compares to its top competitorsIs CHARU stock undervalued or overvalued nowFastest-growing stock picks - jammulinksnews.com
Biodesix, Inc. to Announce Second Quarter 2025 Financial Results on August 7 - Quiver Quantitative
Biodesix Announces Q2 2025 Earnings Call: Key Financial Results Coming August 7 - Stock Titan
12 Best Penny Stocks Under $1 to Buy Now - Insider Monkey
What drives Biodesix Inc. stock priceFree High-Return Strategy Alerts - jammulinksnews.com
Biodesix Skyrockets 18.28%—Is This the Dawn of a Medical Diagnostics Breakout? - AInvest
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):